Archives
FDA Approves MannKind Corp.’s Inhalable Diabetes Drug Afrezza
The U.S. Food and Drug Administration (FDA) has approved MannKind Corp.'s inhalable insulin Afrezza. The approval allows diabetics to use inhalers instead of needles to control insulin levels.
Latest Research Articles
The Solar Atmosphere is Far Larger Than Once Thought
LEGOS: the Perfect Research Tool?
Electric Asteroid Model Will Save Astronauts From a Shocking Surprise [VIDEO]
Lab Grown "Mini Hearts" Help Battle Heart Disease
Bloodsucking Parasite Threatens UK Honeybees
Coronal Eruptions Reluctantly Puff From the Sun: Explained
Neutron Star Brings Astronomers One Step Closer to Proving the Existence of Gravitational Waves
Tiger Leaps onto Boat, Snatches Helpless Fisherman in East India
Monkeys Believe in Winning Streaks
Excessive Alcohol Consumption to Blame for 1 in 10 Deaths
Geeks Get Glasses: Higher Levels of Education are Linked to Nearsightedness
Oldest Animal-Built Reef Discovered in Namibia
MOST POPULAR
-
Weak Spot in Earth's Magnetic Field Raises Concerns for Humanity's Future
-
Spectacular Northern Lights Show Possible in 10 States as Geomagnetic Storm Approaches
-
Earth's Magnetic North Pole Shifts Toward Russia, Scientists Update Its Location
-
Undersea Volcano Off Oregon Coast Could Erupt in 2025 After Scientists Notice 'Swelling'
-
Mount Rainier's Volcanic Activity Closely Watched by Scientists
